Physician profile
Sanmeet Singh
NPI 1295198166
$20,310.51
in general payments reported to CMS, 2019-2025
12 companies · $3,546 in 2025
The $3,546 reported for 2025 was more than what 88% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $36.12 · 2021: $559 · 2022: $8,389 · 2023: $6,833 · 2024: $947 · 2025: $3,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $6,250 · Food and Beverage: $2,899 · Travel and Lodging: $2,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $6,250.00 |
| Food and Beverage | $2,898.64 |
| Travel and Lodging | $2,177.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16,167.91 | 2020-2025 | General - Endochoice, Apollo Esg Nxt System, General - Biliary Devices |
| Olympus Corporation of The Americas | $2,314.07 | 2021-2022 | |
| Olympus America INC. | $864.33 | 2023-2025 | Endoclot Phs, Single Use Aspiration Needle Na-U200h, Visiglide |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $225.20 | 2021-2022 | |
| Abbvie INC. | $176.85 | 2024 | |
| Erbe USA INC | $172.05 | 2023-2024 | Erbe Vio, Hybrid Knife |
| Endogastric Solutions, INC | $170.62 | 2024 | Esophyx |
| Fujifilm Healthcare Americas Corporation | $141.24 | 2023 | Fujifilm |
| Braintree Laboratories, INC. | $27.23 | 2024 | Suflave, Sutab |
| Micro-Tech Endoscopy USA, INC. | $26.29 | 2024 | Eyemax |
| Regeneron Healthcare Solutions, INC. | $14.84 | 2023 | Dupixent |
| Meridian Bioscience INC. | $9.88 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanmeet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.